Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.05
THC's Cash to Debt is ranked lower than
83% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. THC: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
THC' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 0.35
Current: 0.05
0
0.35
Equity to Asset 0.02
THC's Equity to Asset is ranked lower than
93% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. THC: 0.02 )
Ranked among companies with meaningful Equity to Asset only.
THC' s Equity to Asset Range Over the Past 10 Years
Min: 0  Med: 0.17 Max: 0.43
Current: 0.02
0
0.43
Interest Coverage 1.24
THC's Interest Coverage is ranked lower than
90% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 7.52 vs. THC: 1.24 )
Ranked among companies with meaningful Interest Coverage only.
THC' s Interest Coverage Range Over the Past 10 Years
Min: 0.66  Med: 1.23 Max: 1.82
Current: 1.24
0.66
1.82
F-Score: 3
Z-Score: 0.96
WACC vs ROIC
4.86%
7.18%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 6.19
THC's Operating margin (%) is ranked lower than
55% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 6.97 vs. THC: 6.19 )
Ranked among companies with meaningful Operating margin (%) only.
THC' s Operating margin (%) Range Over the Past 10 Years
Min: -8.66  Med: 5.82 Max: 8.21
Current: 6.19
-8.66
8.21
Net-margin (%) -1.18
THC's Net-margin (%) is ranked lower than
80% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.69 vs. THC: -1.18 )
Ranked among companies with meaningful Net-margin (%) only.
THC' s Net-margin (%) Range Over the Past 10 Years
Min: -9.5  Med: 0.18 Max: 13.5
Current: -1.18
-9.5
13.5
ROE (%) -33.54
THC's ROE (%) is ranked lower than
95% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 9.37 vs. THC: -33.54 )
Ranked among companies with meaningful ROE (%) only.
THC' s ROE (%) Range Over the Past 10 Years
Min: -124.98  Med: 2.68 Max: 92.79
Current: -33.54
-124.98
92.79
ROA (%) -0.98
THC's ROA (%) is ranked lower than
79% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. THC: -0.98 )
Ranked among companies with meaningful ROA (%) only.
THC' s ROA (%) Range Over the Past 10 Years
Min: -8.75  Med: 0.19 Max: 13.89
Current: -0.98
-8.75
13.89
ROC (Joel Greenblatt) (%) 14.10
THC's ROC (Joel Greenblatt) (%) is ranked lower than
58% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 19.96 vs. THC: 14.10 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
THC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -14.52  Med: 11.28 Max: 15.25
Current: 14.1
-14.52
15.25
Revenue Growth (3Y)(%) 30.90
THC's Revenue Growth (3Y)(%) is ranked higher than
95% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. THC: 30.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
THC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -13.7  Med: -0.2 Max: 32.4
Current: 30.9
-13.7
32.4
EBITDA Growth (3Y)(%) 20.10
THC's EBITDA Growth (3Y)(%) is ranked higher than
75% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. THC: 20.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
THC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.1  Med: 7.7 Max: 31.5
Current: 20.1
-47.1
31.5
» THC's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-03)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

THC Guru Trades in Q3 2015

Ray Dalio 10,647 sh (New)
Steven Cohen 462,600 sh (+11465.00%)
Jim Simons 197,675 sh (+423.30%)
Larry Robbins 16,490,230 sh (+11.48%)
Louis Moore Bacon Sold Out
Joel Greenblatt Sold Out
Vanguard Health Care Fund Sold Out
Mario Gabelli 15,040 sh (-0.07%)
Paul Tudor Jones 5,600 sh (-71.02%)
» More
Q4 2015

THC Guru Trades in Q4 2015

Louis Moore Bacon 40,156 sh (New)
Paul Tudor Jones 13,400 sh (+139.29%)
Larry Robbins 17,890,230 sh (+8.49%)
Mario Gabelli 15,040 sh (unchged)
Steven Cohen 150,000 sh (unchged)
Ray Dalio Sold Out
Jim Simons Sold Out
Steven Cohen Sold Out
» More
Q1 2016

THC Guru Trades in Q1 2016

David Tepper 348,405 sh (New)
George Soros 31,700 sh (New)
Mario Gabelli 15,050 sh (+0.07%)
Larry Robbins 17,890,230 sh (unchged)
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
» More
Q2 2016

THC Guru Trades in Q2 2016

Joel Greenblatt 545,902 sh (New)
Larry Robbins 17,890,230 sh (unchged)
George Soros Sold Out
David Tepper Sold Out
Mario Gabelli 15,000 sh (-0.33%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:CHE, NAS:LPNT, NAS:SCAI, NYSE:SEM, NAS:AMED, NYSE:AHS, OTCPK:LTGHY, OTCPK:HHCSY, NYSE:CYH, OTCPK:NMHLY, NAS:PAHC, NYSE:ADPT, NAS:SGRY, NAS:HWAY, NAS:AMSG, NYSE:USPH, NYSE:HLS, NAS:LHCG, NAS:PRSC, OTCPK:MFCSF » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp is a health care services company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks.

Tenet Healthcare Corp, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally health care delivery networks with a presence in several urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities it serves. The Company operated 86 hospitals, 475 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. It also offers communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments - hospital operations and other, and Conifer. Its subsidiaries operated 86 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 22,525 licensed beds, serving urban and suburban communities in 14 states. Of those hospitals, 67 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. The Company also owns or controls six accountable care networks - in Florida, California, Illinois, Michigan and Texas - and participates in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and delivery models that seek to align provider reimbursement in a way that encourages improved quality metrics and efficiencies in the total cost of care for an assigned population of patients through cooperation of the providers. The Company's health plans are subject to state and federal laws and regulations. Both federal and state government agencies continue heightened and coordinated civil and criminal enforcement efforts against the health care industry.

Top Ranked Articles about Tenet Healthcare Corp

Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Robbins increased his stake in insurance company Humana
Guru Larry Robbins (Trades, Portfolio), the founder and CEO of Glenview Capital Management, also serves on the Robin Hood Foundation Board of Directors, as well as the board for Teach for America. Read more...
Larry Robbins Raises Stake in Tenet Healthcare Guru's position goes up 11% with purchase of nearly 1.7 million shares
Larry Robbins (Trades, Portfolio), founder, portfolio manager and CEO of hedge fund Glenview Capital Management, raised his stake in Tenet Healthcare Corp. (NYSE:THC) Wednesday by more than 11% with the purchase of 1,697,917 shares for an average price of $36.30 per share. The purchase had a 0.24% impact on Robbins’ portfolio. Read more...

Ratios

vs
industry
vs
history
Forward P/E 12.32
THC's Forward P/E is ranked higher than
85% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 17.86 vs. THC: 12.32 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 4.24
THC's P/B is ranked lower than
73% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. THC: 4.24 )
Ranked among companies with meaningful P/B only.
THC' s P/B Range Over the Past 10 Years
Min: 1.37  Med: 5.21 Max: 100.25
Current: 4.24
1.37
100.25
P/S 0.11
THC's P/S is ranked higher than
98% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. THC: 0.11 )
Ranked among companies with meaningful P/S only.
THC' s P/S Range Over the Past 10 Years
Min: 0.05  Med: 0.32 Max: 0.65
Current: 0.11
0.05
0.65
PFCF 2.43
THC's PFCF is ranked higher than
99% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 22.61 vs. THC: 2.43 )
Ranked among companies with meaningful PFCF only.
THC' s PFCF Range Over the Past 10 Years
Min: 2.32  Med: 41.34 Max: 514.15
Current: 2.43
2.32
514.15
POCF 1.76
THC's POCF is ranked higher than
98% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 14.37 vs. THC: 1.76 )
Ranked among companies with meaningful POCF only.
THC' s POCF Range Over the Past 10 Years
Min: 1.31  Med: 6.63 Max: 15.63
Current: 1.76
1.31
15.63
EV-to-EBIT 13.68
THC's EV-to-EBIT is ranked higher than
73% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 20.23 vs. THC: 13.68 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s EV-to-EBIT Range Over the Past 10 Years
Min: -274.4  Med: 13.85 Max: 1356.9
Current: 13.68
-274.4
1356.9
EV-to-EBITDA 8.23
THC's EV-to-EBITDA is ranked higher than
84% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 14.64 vs. THC: 8.23 )
Ranked among companies with meaningful EV-to-EBITDA only.
THC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -34  Med: 8.3 Max: 22.7
Current: 8.23
-34
22.7
Shiller P/E 66.85
THC's Shiller P/E is ranked lower than
83% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 28.53 vs. THC: 66.85 )
Ranked among companies with meaningful Shiller P/E only.
THC' s Shiller P/E Range Over the Past 10 Years
Min: 63.82  Med: 91.59 Max: 301.91
Current: 66.85
63.82
301.91
Current Ratio 1.13
THC's Current Ratio is ranked lower than
61% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. THC: 1.13 )
Ranked among companies with meaningful Current Ratio only.
THC' s Current Ratio Range Over the Past 10 Years
Min: 1.11  Med: 1.53 Max: 2.38
Current: 1.13
1.11
2.38
Quick Ratio 1.06
THC's Quick Ratio is ranked lower than
58% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. THC: 1.06 )
Ranked among companies with meaningful Quick Ratio only.
THC' s Quick Ratio Range Over the Past 10 Years
Min: 1.03  Med: 1.42 Max: 2.29
Current: 1.06
1.03
2.29
Days Inventory 8.55
THC's Days Inventory is ranked higher than
75% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. THC: 8.55 )
Ranked among companies with meaningful Days Inventory only.
THC' s Days Inventory Range Over the Past 10 Years
Min: 8.55  Med: 10.47 Max: 13.35
Current: 8.55
8.55
13.35
Days Sales Outstanding 50.84
THC's Days Sales Outstanding is ranked lower than
59% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 43.71 vs. THC: 50.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.89  Med: 53.87 Max: 62.54
Current: 50.84
46.89
62.54
Days Payable 36.93
THC's Days Payable is ranked lower than
53% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. THC: 36.93 )
Ranked among companies with meaningful Days Payable only.
THC' s Days Payable Range Over the Past 10 Years
Min: 36.93  Med: 48.85 Max: 56.74
Current: 36.93
36.93
56.74

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.00
THC's 3-Year Average Share Buyback Ratio is ranked higher than
86% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. THC: 2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
THC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -12.9  Med: -0.5 Max: 7.3
Current: 2
-12.9
7.3

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.07
THC's Price/Projected FCF is ranked higher than
74% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 1.68 vs. THC: 1.07 )
Ranked among companies with meaningful Price/Projected FCF only.
THC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.67  Med: 1.26 Max: 222.62
Current: 1.07
0.67
222.62
Price/Median PS Value 0.35
THC's Price/Median PS Value is ranked higher than
98% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. THC: 0.35 )
Ranked among companies with meaningful Price/Median PS Value only.
THC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.2  Med: 1.41 Max: 5.61
Current: 0.35
0.2
5.61
Earnings Yield (Greenblatt) (%) 7.25
THC's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. THC: 7.25 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
THC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 6.6 Max: 15.7
Current: 7.25
0.1
15.7
Forward Rate of Return (Yacktman) (%) 34.05
THC's Forward Rate of Return (Yacktman) (%) is ranked higher than
92% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.20 vs. THC: 34.05 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
THC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -103.1  Med: 0.5 Max: 34.05
Current: 34.05
-103.1
34.05

More Statistics

Revenue (TTM) (Mil) $19,630
EPS (TTM) $ -2.33
Beta0.98
Short Percentage of Float13.02%
52-Week Range $20.93 - 40.07
Shares Outstanding (Mil)99.52

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 19,245 20,139 21,445
EPS ($) 1.70 1.82 3.04
EPS w/o NRI ($) 1.70 1.82 3.04
EPS Growth Rate
(3Y to 5Y Estimate)
26.40%
Dividends Per Share ($)
» More Articles for THC

Headlines

Articles On GuruFocus.com
Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Dec 06 2015 
Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon Oct 25 2015 
Larry Robbins Raises Stake in Tenet Healthcare Oct 05 2015 
Obamacare Makes HCA a Buy Aug 24 2015 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Distressed Debt Investor Paul Singer Buys Citrix Systems Jun 11 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Tenet Healthcare And United Surgical JV For $1.93 Billion Mar 24 2015 
Mario Gabelli’s Equity Income Fund Q3 2014 Commentary Oct 29 2014 
Time to Buy Tenet Healthcare? Aug 22 2014 

More From Other Websites
Ulta Salon: 3 Good Reasons the Short-Sellers Are Right Sep 27 2016
2 Oversold Health Care Service Stocks in Wake of Community Health Review Sep 23 2016
Canopy Health Selects Conifer Health for Value-Based Care Services Sep 22 2016
Skechers, Ascena Group Join Wednesday’s 52-Week Low Club Sep 21 2016
TENET HEALTHCARE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Sep 16 2016
Fountain Place's largest tenant to relocate to Renaissance Tower in downtown Dallas Sep 15 2016
Health-Services Spending Takes Off, Raising Political Risk Sep 09 2016
Tenet to Present at Investor Conferences in September Sep 02 2016
Tenet to Present at Investor Conferences in September Sep 02 2016
Why Tenet Healthcare (THC) Could Be Positioned for a Slump Aug 22 2016
Hospital stocks take a hit as Aetna retreats from Obamaca... Aug 16 2016
TENET HEALTHCARE CORP Financials Aug 05 2016
ETF’s with exposure to Tenet Healthcare Corp. : August 4, 2016 Aug 04 2016
5 Stocks, 5 trades: Kate Spade, Papa John's and more Aug 03 2016
Tenet Healthcare Corporation -- Moody's: Tenet's announcement of a settlement agreement in principal... Aug 02 2016
Edited Transcript of THC earnings conference call or presentation 2-Aug-16 2:00pm GMT Aug 02 2016
Five Stocks Catch Investors’ Attention on the Back of Financial Results Aug 02 2016
Tenet Healthcare Corp. breached its 50 day moving average in a Bearish Manner : THC-US : August 2,... Aug 02 2016
Stock Open Lower; Texas Roadhouse, Chuy's Take Hits Aug 02 2016
Tenet Healthcare agrees to plead guilty in Atlanta kickback scheme, will pay $514 million Aug 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)